Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
15/07/2026 01:02
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine July 15 (Reuters) - Taiwan-based contract drugmaker Bora Pharmaceuticals 6472.TW will partner with Insilico Medicine 3696.HK on a collaboration potentially valued at over $2.5 billion if fully implemented, the drug discovery firm said on Wednesday.
(Reporting by Andrew Silver in Shanghai; Editing by Muralikumar Anantharaman)
Recent news on BORA PHARMACEUTICALS
See all newsAI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln